Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 5/20 | 0.41 |
| ▸ | TYR | P14679 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 6/20 | 0.37 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14485196 | 1.00 | GPR35 (0.41) | GPR35ALOX5TYRCYP3A4MEN1 | |
| SCHEMBL8974573 | 1.00 | GPR35 (0.41) | GPR35ALOX5TYRCYP3A4MEN1 | |
| SCHEMBL1422210 | 1.00 | GPR35 (0.41) | GPR35ALOX5TYRCYP3A4MEN1 | |
| SCHEMBL1422465 | 0.92 | TYR (0.37) | GPR35ALOX5TYRCYP3A4MEN1 | |
| SCHEMBL12730032 | 0.85 | GPR35 (0.41) | GPR35ALOX5TYRCYP3A4MEN1 | |
| SCHEMBL15412792 | 0.83 | THRB (0.37) | GPR35CYP3A4MEN1MAPTTSHR | |
| SCHEMBL2855414 | 0.81 | ALOX5 (0.39) | GPR35ALOX5TYRCYP3A4MEN1 | |
| SCHEMBL2847059 | 0.81 | ALOX5 (0.42) | GPR35ALOX5TYRCYP3A4MEN1 | |
| SCHEMBL2855365 | 0.81 | ALOX5 (0.42) | GPR35ALOX5TYRCYP3A4MEN1 | |
| SCHEMBL2855161 | 0.81 | GPR35 (0.39) | GPR35ALOX5TYRCYP3A4MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9623123-B2 | Fluorescent conjugated polymers with a bodipy-based backbone and uses thereof | MICHIGAN TECHNOLOGICAL UNIVERSITY (US) | 2017-04-18 | — | — | US | disclosed |
| US-20170014532-A1 | FLUORESCENT CONJUGATED POLYMERS WITH A BODIPY-BASED BACKBONE AND USES THEREOF | UNIV MICHIGAN TECH (US) | 2017-01-19 | — | — | US | disclosed |
| US-9412949-B2 | Fluorescent conjugated polymers with a bodipy-based backbone and uses thereof | MICHIGAN TECHNOLOGICAL UNIVERSITY (US) | 2016-08-09 | — | — | US | disclosed |
| US-20120070382-A1 | FLUORESCENT CONJUGATED POLYMERS WITH A BODIPY-BASED BACKBONE AND USES THEREOF | MICHIGAN TECHNOLOGICAL UNIVERSITY (US) | 2012-03-22 | — | — | US | disclosed |
| WO-2010075512-A1 | POLYMERS WITH BODIPY-BASED BACKBONE FOR SOLAR CELLS | MICHIGAN TECHNOLOGICAL UNIVERSITY (US) | 2010-07-01 | — | — | WO | disclosed |
| WO-2010075514-A1 | FLUORESCENT CONJUGATED POLYMERS WITH A BODIPY-BASED BACKBONE AND USES THEREOF | MICHIGAN TECHNOLOGICAL UNIVERSITY (US) | 2010-07-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170014532-A1 | FLUORESCENT CONJUGATED POLYMERS WITH A BODIPY-BASED BACKBONE AND USES THEREOF | TLR3, TLR5, PARP15 | GPR35 2207/4885ALOX5 2164/4885TYR 2195/4885 |
| US-20120070382-A1 | FLUORESCENT CONJUGATED POLYMERS WITH A BODIPY-BASED BACKBONE AND USES THEREOF | TLR3, TLR5, PARP15 | GPR35 2207/4885ALOX5 2164/4885TYR 2195/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.